Literature DB >> 23348051

Does the U.S. health care sector suffer from Baumol's cost disease? Evidence from the 50 states.

Laurie J Bates1, Rexford E Santerre.   

Abstract

This study examines if health care costs in the United States are affected by Baumol's cost disease. It relies on an empirical test proposed by Hartwig (2008) and extended by Colombier (2010) and uses a panel data set of 50 states over the 1980-2009 period. The results suggest that health care costs grow more rapidly when economy-wide wage increases exceed productivity gains. The findings are fairly robust with respect to time- and state-fixed effects, individual state time trends, and two-stage least square estimation. Consequently, this study suggests that the U.S. health care sector suffers from Baumol's cost disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Mesh:

Year:  2012        PMID: 23348051     DOI: 10.1016/j.jhealeco.2012.12.003

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  3 in total

1.  Convergence and determinants of health expenditures in OECD countries.

Authors:  Son Hong Nghiem; Luke Brian Connelly
Journal:  Health Econ Rev       Date:  2017-08-17

2.  Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis.

Authors:  Jörg Mahlich; Arne Bartol; Srirangan Dheban
Journal:  Health Econ Rev       Date:  2021-01-16

3.  How production networks amplify economic growth.

Authors:  James McNerney; Charles Savoie; Francesco Caravelli; Vasco M Carvalho; J Doyne Farmer
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.